Your browser doesn't support javascript.
loading
[Treatments for rare ovarian tumors: What's new?] / Avancées thérapeutiques dans la prise en charge des tumeurs rares malignes ovariennes.
Lebreton, Coriolan; Quesada, Stanislas; Bini, Marta; Babin, Guillaume; Rossi, Léa; Chopin, Nicolas; Croce, Sabrina; Hartog, Cécile; Renaud, Tiphaine; Gaillard, Anne-Lise; Petit, Adeline; Serre, Anne-Agathe; Trédan, Olivier; Rowinski, Elise; Cockenpot, Vincent; Treilleux, Isabelle; Rousset-Jablonski, Christine; Méeus, Pierre; Guyon, Frédéric; Ray-Coquard, Isabelle.
Afiliação
  • Lebreton C; Institut Bergonié, département d'oncologie médicale, Bordeaux, France; University of Bordeaux, ARTiSt Lab, Inserm U1312, Bordeaux, France. Electronic address: c.lebreton@bordeaux.unicancer.fr.
  • Quesada S; Institut régional du cancer de Montpellier, département d'oncologie médicale, Montpellier, France.
  • Bini M; Instituto Nazionale dei Tumori, Milano, Italie.
  • Babin G; University of Bordeaux, ARTiSt Lab, Inserm U1312, Bordeaux, France; Institut Bergonié, département de chirurgie, Bordeaux, France.
  • Rossi L; Centre Léon-Bérard, département de chirurgie, Lyon, France.
  • Chopin N; Centre Léon-Bérard, département de chirurgie, Lyon, France.
  • Croce S; Institut Bergonié, département de biopathologie, Bordeaux, France; University of Bordeaux, SARCOTARGET Lab, Inserm U1312, Bordeaux, France.
  • Hartog C; University of Bordeaux, ARTiSt Lab, Inserm U1312, Bordeaux, France; Centre Léon-Bérard, département de chirurgie, Lyon, France.
  • Renaud T; Institut Bergonié, département de gynécologie médicale, Bordeaux, France.
  • Gaillard AL; Institut Bergonié, département de radiologie, Bordeaux, France.
  • Petit A; Institut Bergonié, département de radiothérapie et curiethérapie, Bordeaux, France.
  • Serre AA; Centre Léon-Bérard, département de radiothérapie et curiethérapie, Lyon, France.
  • Trédan O; Centre Léon-Bérard, département d'oncologie médicale, Lyon, France.
  • Rowinski E; Centre Léon-Bérard, département d'oncologie médicale, Lyon, France.
  • Cockenpot V; Centre Léon-Bérard, département de biopathologie, Lyon, France.
  • Treilleux I; Centre Léon-Bérard, département de biopathologie, Lyon, France.
  • Rousset-Jablonski C; Centre Léon-Bérard, département de chirurgie, Lyon, France.
  • Méeus P; Centre Léon-Bérard, département de chirurgie, Lyon, France.
  • Guyon F; Institut Bergonié, département de chirurgie, Bordeaux, France.
  • Ray-Coquard I; Centre Léon-Bérard, département d'oncologie médicale, Lyon, France; University of Claude-Bernard Lyon 1, health services and performance research lab (EA 7425 HESPER), Lyon, France.
Bull Cancer ; 110(7-8): 818-824, 2023.
Article em Fr | MEDLINE | ID: mdl-37045734
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas Tipo de estudo: Clinical_trials / Guideline / Incidence_studies / Prognostic_studies Limite: Female / Humans Idioma: Fr Revista: Bull Cancer Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas Tipo de estudo: Clinical_trials / Guideline / Incidence_studies / Prognostic_studies Limite: Female / Humans Idioma: Fr Revista: Bull Cancer Ano de publicação: 2023 Tipo de documento: Article